Winning Trade Idea

Recommendation

Service : FOR THE GLORY | Trader : JOHN KROLIKOWSKI JR | Trade Date : 10/21/20

$PRPH - ProPhase Labs

Buy Long

Trade

79.49 %

Target

$7.80

Issue Price

$14.00

Target Price

10/21/21

Target Date

$3.99

Stop Loss

Trade Closed - WINNER

Hit Target Price

Reason

70.00 %

P/L %

$13.26

Close Price

81

Days Held

01/11/21

Closed Date

To view trade details and get more recommendations from this trader Follow

PRPH - ProPhase Labs

$15.99 0[0%]

+Watchlist

2 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$15.99	Open
Volume	500	Market Cap	157.93M
Yield		Last Dividend

Day

52 Week

The Daily Biotech Pulse: Bristol-Myers S...	10/07/20
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) 10X ...

The Daily Biotech Pulse: Pfizer, BioNTec...	10/06/20
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) 10X ...

58 Biggest Movers From Friday	10/05/20
Gainers Xtant Medical Holdings, Inc. (NYSE: XTNT ) shares climbed 91.4% to close at $1.57 on Friday after the company announced the closing of debt re...

62 Biggest Movers From Friday	09/21/20
Gainers COMPASS Pathways Plc (NASDAQ: CMPS ) shares jumped 70.6% to close at $29.00 on Friday after pricing its IPO at $17 per share. Cassava Sciences...

ProPhase Labs Reports Financial Results ...	03/25/20
DOYLESTOWN, Pennsylvania, March 25, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today announced its net sales we...

ProPhase Labs reports Q1 results	05/14/19
No summary available.

ProPhase Labs reports FY results	03/26/19
No summary available.

New finance chief at ProPhase Labs	01/18/19
No summary available.

New finance chief at ProPhase Labs	01/18/19
No summary available.

ProPhase Labs declares $0.25 dividend	12/26/18
No summary available.

ProPhase Labs declares $0.25 dividend	12/26/18
No summary available.

ANALYST RATINGS

0 analyst ratings (Last 3 months)

0.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

FINANCE

Total Revenue	$1.3B	Total Liabilities	$2.1B
Cost of Revenue	$2.5B	Total cash flow	$3.2
Total Assets	$29.98B

HOLDERS

% Insider	12.52%	% Institutional	76.43%

Top 10 Institutional Owners

Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%

TRADERS TRACKING $PRPH

Service Name	Trader	% Success
FOR THE GLORY	JOHN KROLIKOWSKI JR	86.00 %	Follow
OG	AL GORE RHYTHMS	33.00 %	Follow

SHOW ALL TRADERS